Myrexis, Inc. MYRX today announced that Adrian N. Hobden, Ph.D. has
resigned as President, Chief Executive Officer and a member of the Board of
Directors, effective July 21, 2011. The Board of Directors has appointed
Robert J. Lollini, the Company's Chief Financial Officer, as interim President
and Chief Executive Officer. Mr. Lollini will also continue has duties as
Chief Financial Officer. The Board plans to initiate a search for a new CEO,
looking at both internal and external candidates. In addition, Dr. Hobden has
agreed to serve as a consultant to the company for three months to assist in
the transition.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in